Clinical and Laboratory Haematology 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A ten ‐color tube with dried antibody reagents for the screening of hematological malignancies
ConclusionsThe DST is an efficient solution for screening hematological malignancies with improved quality, productivity, standardization, and sustainability. These improvements could benefit patients by providing faster diagnoses using a higher quality and lower cost reagent. (Source: Clinical and Laboratory Haematology)
Source: Clinical and Laboratory Haematology - October 4, 2017 Category: Hematology Authors: R. P. Correia, A. Rajab, L. C. Bento, A. M. Alexandre, A. C. Vaz, D. Schimidell, E. C. Pedro, F. S. Perin, S. T. Nozawa, R. S. Barroso, N. S. Bacal Tags: ORIGINAL ARTICLE Source Type: research
Bleeding score in Type 1 von Willebrand disease patients using the ISTH ‐BAT questionnaire
ConclusionThe ISTH‐BAT BS is designed to reflect the severity of bleeding. Our results demonstrate the inherent variability of this bleeding pattern. We also found that the ISTH‐BAT BS significantly correlated with VWF: Ag and VWF: CB. (Source: Clinical and Laboratory Haematology)
Source: Clinical and Laboratory Haematology - October 1, 2017 Category: Hematology Authors: A. Pathare, S. Al Omrani, F. Al Hajri, N. Al Obaidani, B. Al Balushi, K. Al Falahi Tags: ORIGINAL ARTICLE Source Type: research
Multiple centre evaluation study of ADAMTS13 activity and inhibitor assays
ConclusionWith close attention to normal ranges, commercial kits are suitable for use in the clinical diagnosis of thrombotic microangiopathies and frozen transportation of samples between sites is a suitable approach. However, a robust external quality control system is essential to provide an independent evaluation of changes in kit production. (Source: Clinical and Laboratory Haematology)
Source: Clinical and Laboratory Haematology - October 1, 2017 Category: Hematology Authors: K. Langley, R. Fretwell, S. Kitchen, S. MacDonald, T. Dutt, P. Baker, D. Singh, V. McDonald, C. Hughes, P. Murphy, M. Scully Tags: ORIGINAL ARTICLE Source Type: research
Digital microscopy as a screening tool for the diagnosis of hereditary hemolytic anemia
ConclusionDM holds a promise as a useful screening tool in the diagnosis of hereditary hemolytic anemia by detecting and quantifying distinct morphological changes in RBCs in patients with various forms of hereditary hemolytic anemia. (Source: Clinical and Laboratory Haematology)
Source: Clinical and Laboratory Haematology - October 1, 2017 Category: Hematology Authors: R. Huisjes, W. W. Solinge, M. D. Levin, R. Wijk, J. A. Riedl Tags: ORIGINAL ARTICLE Source Type: research
Minimal residual disease in multiple myeloma: Benefits of flow cytometry
This article provides data about the methods used for MRD monitoring and describes the advances in the field of flow cytometry. (Source: Clinical and Laboratory Haematology)
Source: Clinical and Laboratory Haematology - October 1, 2017 Category: Hematology Authors: I. V. Galtseva, Y. O. Davydova, N. M. Kapranov, H. L. Julhakyan, L. P. Mendeleeva Tags: REVIEW ARTICLE Source Type: research
